Acadia Healthcare Company, Inc. (ACHC) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The company's financial performance in Q1 2026 showed strong growth in revenue, net income, EBITDA, and operating margin, indicating operational efficiency and effective cost management. Despite the lack of discussion on strategic initiatives, the positive financial metrics and improved cash flow suggest a favorable market reaction. The absence of significant risks or negative trends in the Q&A section further supports a positive outlook. Given these factors, a positive sentiment rating is justified, anticipating a stock price increase between 2% to 8%.
Key Financial Performance
Revenue Acadia Healthcare reported revenue of $700 million for Q1 2026, representing a 10% increase year-over-year. The growth was attributed to higher patient volumes and improved pricing strategies.
Net Income Net income for Q1 2026 was $80 million, up 15% compared to the same period last year. This increase was driven by operational efficiencies and cost management initiatives.
EBITDA The company achieved an EBITDA of $150 million in Q1 2026, reflecting a 12% growth year-over-year. The improvement was due to enhanced operational performance and economies of scale.
Operating Margin Operating margin improved to 21% in Q1 2026, up from 19% in Q1 2025. This was primarily due to better cost controls and increased revenue.
Cash Flow Cash flow from operations was $120 million in Q1 2026, a 20% increase year-over-year. The rise was attributed to improved collections and higher profitability.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Forward-Looking Statements: The company's forward-looking statements regarding expected financial performance for 2026 and beyond may be affected by important factors, leading to potential differences in actual operations and results.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Acadia Healthcare
Associates Inc
Benjamin Hendrix
Benjamin Mayo
Brian Tanquilut
CEO Director
Cowen Research
Debra Osteen
Director Benjamin
Division Benjamin
Division Brian
Division Gillmor
Division Mok
Division Pito
Division Ransom
Division Ryan
Division day
EDT Debra
Gillmor KeyBanc
Healthcare Inc
Hendrix RBC
Inc EDT
Instructions event
Jefferies LLC
LLC Research
Langston TD
Mayo Leerink
Mok Barclays
Osteen CEO
Ransom Raymond
Raymond Associates
Ryan Langston
conference Chief
event conference
ACHC Transcript
Acadia Healthcare Company, Inc. (ACHC) Q1 2026 Earnings Call Transcript
Positive5-1
The company's financial performance in Q1 2026 showed strong growth in revenue, net income, EBITDA, and operating margin, indicating operational efficiency and effective cost management. Despite the lack of discussion on strategic initiatives, the positive financial metrics and improved cash flow suggest a favorable market reaction. The absence of significant risks or negative trends in the Q&A section further supports a positive outlook. Given these factors, a positive sentiment rating is justified, anticipating a stock price increase between 2% to 8%.
Acadia Healthcare Company, Inc. (ACHC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Neutral3-10
Acadia Healthcare Company, Inc. (ACHC) Presents at Leerink Global Healthcare Conference 2026 Transcript
Neutral3-9
Acadia Healthcare Company, Inc. (ACHC) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript
Neutral3-2
ACHC Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
